Once more: prevention of nausea and emesis in cancer treatment

Editorial

M S Aapro. Support Care Cancer. 1994 May.

. 1994 May;2(3):141-2.

doi: 10.1007/BF00417470.

No abstract available

Comment on

Cost-effectiveness analysis of antiemetic treatment.
Bleiberg H, Autier P, Michaux D. Bleiberg H, et al. Support Care Cancer. 1994 May;2(3):145-9. doi: 10.1007/BF00417472. Support Care Cancer. 1994. PMID: 8032699
Antiemetics in cancer chemotherapy: historical perspective and current state of the art.
Tonato M, Roila F, Del Favero A, Ballatori E. Tonato M, et al. Support Care Cancer. 1994 May;2(3):150-60. doi: 10.1007/BF00417473. Support Care Cancer. 1994. PMID: 8032700 Review.
Ondansetron plus dexamethasone versus metoclopramide plus dexamethasone plus diphenhydramine in cisplatin-treated patients with ovarian cancer. Italian Group for Antiemetic Research.
[No authors listed] [No authors listed] Support Care Cancer. 1994 May;2(3):167-70. Support Care Cancer. 1994. PMID: 8032702 Clinical Trial.